Cargando…

Clinical and genetic characteristics of female dystrophinopathy carriers

The present study aimed to determine the genetic status of manifesting carriers (MCs) of Duchenne muscular dystrophy (DMD)/Becker muscular dystrophy (BMD) and asymptomatic carriers with a family history of DMD/BMD, and identify potential simple and reliable methods for screening dystrophinopathy car...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhong, Jingzi, Xie, Yanshu, Bhandari, Vidata, Chen, Gang, Dang, Yiwu, Liao, Haixia, Zhang, Jiapeng, Lan, Dan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423608/ https://www.ncbi.nlm.nih.gov/pubmed/30816495 http://dx.doi.org/10.3892/mmr.2019.9982

Ejemplares similares

Use of RNA-sequencing to detect abnormal transcription of the collagen α-2 (VI) chain gene that can lead to Bethlem myopathy
por: Zhong, Jingzi, et al.
Publicado: (2021)

Clinical and Genetic Characterization of Female Dystrophinopathy
por: Lee, Seung Ha, et al.
Publicado: (2015)

Medical Attitudes Survey for Female Dystrophinopathy Carriers in Japan
por: Kobayashi, Michio, et al.
Publicado: (2018)

A manifesting female carrier of Duchenne muscular dystrophy: importance of genetics for the dystrophinopathies
por: Quak, Zhi Xuan, et al.
Publicado: (2023)

Reassessing carrier status for dystrophinopathies
por: Newcomb, Tara M., et al.
Publicado: (2016)

The Expanding Spectrum of Dystrophinopathies: HyperCKemia to Manifest Female Carriers
por: Suthar, Renu, et al.
Publicado: (2021)

Comprehensive genetic characteristics of dystrophinopathies in China
por: Ma, Peipei, et al.
Publicado: (2018)

Prognostic value of X-chromosome inactivation in symptomatic female carriers of dystrophinopathy
por: Juan-Mateu, Jonàs, et al.
Publicado: (2012)

Correction to: Comprehensive genetic characteristics of dystrophinopathies in China
por: Ma, Peipei, et al.
Publicado: (2021)

Serum MyomiRs as Biomarkers for Female Carriers of Duchenne/Becker Muscular Dystrophy
por: Zhang, Jiapeng, et al.
Publicado: (2020)

Corrigendum: Serum MyomiRs as Biomarkers for Female Carriers of Duchenne/Becker Muscular Dystrophy
por: Zhang, Jiapeng, et al.
Publicado: (2020)

Comprehensive analysis for genetic diagnosis of Dystrophinopathies in Japan
por: Okubo, Mariko, et al.
Publicado: (2017)

Late-Onset Dystrophinopathy
por: Singh, Ranjan K
Publicado: (2021)

MicroRNAs in Dystrophinopathy
por: Lee, Ahyoung, et al.
Publicado: (2022)

Long‐read whole‐genome sequencing for the genetic diagnosis of dystrophinopathies
por: Xie, Zhiying, et al.
Publicado: (2020)

Aldosterone defects in infants and young children with hyperkalemia: A single center retrospective study
por: Liu, Xu, et al.
Publicado: (2023)

EMQN best practice guidelines for genetic testing in dystrophinopathies
por: Fratter, Carl, et al.
Publicado: (2020)

Cardiac care of children with dystrophinopathy and females carrying DMD-gene variations
por: Bourke, John, et al.
Publicado: (2022)

Detection of gonosomal mosaicism by ultra‐deep sequencing and droplet digital PCR in patients with Emery–Dreifuss muscular dystrophy
por: Xie, Yanshu, et al.
Publicado: (2023)

Involvement of adiponectin in the pathogenesis of dystrophinopathy
por: Abou-Samra, Michel, et al.
Publicado: (2015)

Advances in Dystrophinopathy Diagnosis and Therapy
por: Saad, Fawzy A., et al.
Publicado: (2023)

Cardiac Involvement in Dystrophin-Deficient Females: Current Understanding and Implications for the Treatment of Dystrophinopathies
por: Lim, Kenji Rowel Q., et al.
Publicado: (2020)

Clinical and genetic spectra in patients with dystrophinopathy in Korea: A single-center study
por: Yun, UnKyu, et al.
Publicado: (2021)

Efficacy and safety of hydrokinesitherapy in patients with dystrophinopathy
por: Suslov, V. M., et al.
Publicado: (2023)

Novel miRNA Biomarkers for Patients With Duchenne Muscular Dystrophy
por: Meng, Qi, et al.
Publicado: (2022)

Ataluren treatment of patients with nonsense mutation dystrophinopathy
por: Bushby, Katharine, et al.
Publicado: (2014)

Molecular Diagnosis in 100% of Dystrophinopathies: Are We There Yet?
por: Pegoraro, Elena
Publicado: (2021)

Study of Dystrophinopathy in Eastern Uttar Pradesh Population of India
por: Kumari, Preeti, et al.
Publicado: (2018)

Needs management in families affected by childhood-onset dystrophinopathies
por: Conway, Kristin M, et al.
Publicado: (2019)

Functional changes in Becker muscular dystrophy: implications for clinical trials in dystrophinopathies
por: Bello, Luca, et al.
Publicado: (2016)

Genetic Profile of the Dystrophin Gene Reveals New Mutations in Colombian Patients Affected with Muscular Dystrophinopathy
por: Triana-Fonseca, Paula, et al.
Publicado: (2021)

Serum creatinine as a biomarker for dystrophinopathy: a cross-sectional and longitudinal study
por: Wang, Liang, et al.
Publicado: (2021)

A deep learning model for diagnosing dystrophinopathies on thigh muscle MRI images
por: Yang, Mei, et al.
Publicado: (2021)

X-Linked Dilated Cardiomyopathy: A Cardiospecific Phenotype of Dystrophinopathy
por: Nakamura, Akinori
Publicado: (2015)

Genotypes and Phenotypes of DMD Small Mutations in Chinese Patients With Dystrophinopathies
por: Wang, Liang, et al.
Publicado: (2019)

Exploring the acceptability of implantable defibrillators in patients with cardiac dystrophinopathy and carers
por: Hiermeier, Ursula M, et al.
Publicado: (2020)

Very Low Residual Dystrophin Quantity Is Associated with Milder Dystrophinopathy
por: de Feraudy, Yvan, et al.
Publicado: (2020)

Proteomic profiling of the interface between the stomach wall and the pancreas in dystrophinopathy
por: Dowling, Paul, et al.
Publicado: (2021)

Pre-clinical drug tests in the mdx mouse as a model of dystrophinopathies: an overview
por: DE LUCA, ANNAMARIA
Publicado: (2012)

Interplay between DMD Point Mutations and Splicing Signals in Dystrophinopathy Phenotypes
por: Juan-Mateu, Jonàs, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_fcm3fehed2p4a2gdgsvfeh4ost